Operation Sindoor & Market Moves: What’s Next?

Operation Sindoor shook headlines—and not just in India. As missiles hit alleged terror camps across Pakistan and PoJK, global markets watched with raised eyebrows while ours… barely flinched.

Nifty ended the day up 0.14%, driven by a strong auto rally and a 5% surge in Tata Motors on its big demerger buzz. Bank Nifty joined the party, rising 0.63%, while FMCG stocks quietly slipped into the red—dragged down by a 3.5% fall in Asian Paints.

So, is the market ignoring geopolitical tension—or is this the calm before the next wave?

Let’s break down what Operation Sindoor means for market sentiment, which sectors are heating up, and what signals you should be watching before placing your next trade 👇

Operation Sindoor: Market Impact & What History Tells Us

India’s latest military move—Operation Sindoor—has captured global attention. But if you were expecting markets to panic, think again. The Nifty actually closed higher yesterday, thanks to strong support from autos and banks.

So, is the market ignoring geopolitical tensions?

Not quite. It’s more like… seasoned.

History shows us that Indo-Pak tensions usually create short-term dips, but the medium-term market outlook often turns surprisingly positive.

What Past Conflicts Tell Us

Let’s take a quick look at how markets have behaved in previous high-stress situations:

Event	Max Drawdown	3-Month Return	6-Month Return
Kargil War (1999)	-0.80%	+32%	+37%
Parliament Attack (2001)	-13.9%	+5%	-1%
26/11 Mumbai Attacks	-7.73%	+1%	+50%
Uri Surgical Strikes (2016)	-2.1%	-8%	+4%
Pulwama & Balakot (2019)	-1.8%	+4%	+3%

Even though the Nifty tends to dip by ~5% immediately, average returns over 3–6 months range from 7% to 19%, as per Bajaj Broking. The takeaway? Markets may wobble—but they bounce back stronger.

And with the Nifty currently around 24,414, the room for short-term correction exists—but panic might not pay.

Defence Stocks in Focus

With Operation Sindoor raising national security stakes, the defence sector could see renewed interest from both retail and institutional players.

🚀 Curious which defence stocks could gain from this backdrop?
Read our deep-dive blog here 👉 Operation Sindoor: Defence Stocks to Watch

Nifty 50 Analysis – Post-Operation Sindoor Bounce

After a surprising show of strength post-Operation Sindoor, the Nifty closed at 24,414, up just 0.14%—but that minor green has more meaning than meets the eye.

The index has bounced cleanly off its 9-day EMA (24,143) and is holding firm. The volume wasn’t euphoric, but it was solid—suggesting that institutional buyers may not be fleeing just yet, even with geopolitical tension in the air.

But now comes the tricky part: the resistance zone.

Chart Observations

• Nifty is now knocking on a heavy resistance wall around 24,581–24,789, where supply has stepped in before.
• That said, the gap-up post-strike shows confidence—possibly from those who believe the market has priced in the worst.
• The gap zone between 22,900–23,800 still looms large. If sentiment turns, the index could slide back to fill it.

Strategy Snapshot:

Setup	Entry Zone	Target Range	SL
Bullish Breakout	Above 24,600	24,900–25,100	24,400
Bearish Reversal	Below 24,140	23,860–23,800	24,300

News & Stocks in Focus – What Happened & Who’s Impacted

From IPO buzz to big export wins, yesterday’s news wasn’t loud—but it was full of signals. Let’s break it down so anyone can understand what happened and which stocks it could impact.

ICRA: ₹7,000 Cr Worth of Co-Working IPOs Coming Soon

Credit rating agency ICRA says India’s co-working office space is booming. From 80 million sq ft at the end of 2024, it could jump to 125 million by 2027—a 21–22% growth rate. Riding this wave, five co-working firms (like WeWork India, Smartworks, IndiQube) plan IPOs worth over ₹7,000 crore in the next 12–18 months.

Impacted Stocks:

• Awfis Space Solutions (recently listed) – already a listed co-working play
• Real estate developers like Brigade, Prestige, Mindspace REIT – they lease office spaces to such companies

Simple Energy’s ₹3,000 Cr IPO Pl

EV two-wheeler company Simple Energy, based in Bengaluru, announced it will raise ₹3,000 crore via IPO by FY27. The goal? Expand production, open 500 stores (up from 15), and grab a 5% share of India’s EV scooter market. Right now, it holds just 0.3%.

Impacted Stocks:

• EV-related plays like Greaves Cotton, Olectra Greentech, Sona BLW, Amara Raja, and Exide Industries (battery suppliers)
• Hero MotoCorp, TVS Motor – face competition in the premium EV space

Welspun Corp Bags ₹1,950 Cr Export Deal

Welspun Corp landed a ₹1,950 crore export order to supply special pipelines (LSAW pipes and bends) used to carry oil, gas, and water across long distances. This pushes their total global order book to ₹19,300 crore.

Impacted Stock:

• Welspun Corp (NSE: WELCORP) – directly benefits from the deal

This isn’t a flashy story—but it’s huge for Welspun’s revenues and cash flow over the next few quarters. Such large infra orders signal a healthy export pipeline and growing demand for industrial materials.

Mouri Tech Files for ₹1,500 Cr IPO

Hyderabad-based Mouri Tech, an IT services and digital solutions company, has filed draft papers for a ₹1,500 crore IPO. It plans to raise ₹440 crore via fresh shares and the rest through an offer-for-sale. Funds will go toward reducing US subsidiary debt, working capital, and general use.

Impacted Stocks:

• Mid-cap IT companies like Sonata Software, Cyient, Mphasis, and Persistent Systems – may move on positive sentiment

Tata Elxsi’s AI Leap into Sports Medicine

Tata Elxsi is partnering with ECOSEP, a European body of sports doctors, to use artificial intelligence in diagnosing injuries, preventing them, and creating custom recovery plans for athletes.

Impacted Stock:

• Tata Elxsi (NSE: TATAELXSI) – directly involved

Tata Elxsi is known for innovation in automotive and healthcare tech. Now it’s entering sports medicine—a growing, tech-hungry field. It’s a smart vertical expansion using their existing AI strengths.

Suzlon & Integrum Win 100 MW Wind Projects from BPCL

BPCL awarded contracts to both Suzlon Energy and Integrum Energy to build 50 MW wind power projects each in Madhya Pradesh and Maharashtra. This supports BPCL’s goal of having 10 GW of clean energy by 2040.

Impacted Stocks:

• Suzlon Energy (NSE: SUZLON) – directly gains from this win
• Bharat Petroleum (NSE: BPCL) – showing continued green energy push

Clean energy orders are picking up again, and Suzlon keeps landing deals quietly. It’s not a breakout story yet—but consistent execution like this strengthens its turnaround case.

Technical Radar – JK Paper Ltd

While the market was busy digesting the shockwaves from Operation Sindoor, JK Paper quietly showed signs of life on the charts.

The stock closed at ₹307.65, just above its 9-day EMA of ₹305—a level it hasn’t confidently cleared in a while. It’s not a breakout yet, but it’s a nudge in the right direction.

What’s interesting here is that the stock has bounced off the ₹295 support zone, forming a base. If it can continue this pattern of higher lows, we could be looking at an early trend reversal attempt.

What the Chart is Saying:

• First close above EMA after a downtrend = soft signal of buyer return.
• Volume is low though, so confidence is missing for now.
• Major hurdle: ₹315–₹320 zone, the previous swing high. That’s where bulls either take control—or give up again.

Levels to Keep in Sight:

• Support: ₹305, ₹295
• Resistance: ₹315 (initial), ₹320 (key breakout level)
• Upside potential: Above ₹320, there’s space toward ₹340
• Risk zone: A close below ₹295 could reopen downside to ₹280–₹265

Post–Operation Sindoor Sentiment?

With Operation Sindoor creating geopolitical noise, defensive and domestic themes may get preference. JK Paper fits that quiet, India-focused profile. It’s not rallying yet, but it’s holding structure—and sometimes, that’s the first clue before smart money steps in.

Small-Cap Stock of the Day – Marksans Pharma Ltd

While the headlines were dominated by missiles and demergers, Marksans Pharma quietly climbed 3.27%—and the chart wasn’t the only thing looking healthy.

This mid-cap pharma company operates in the formulation business, making everything from over-the-counter (OTC) meds to prescription drugs. And with OTC contributing 74% of its revenue, this isn’t your typical hospital-supplier stock—it’s more about everyday health solutions.

What’s in the Medicine Cabinet?

Marksans offers:

• Painkillers, cough & cold meds, digestion aids, multivitamins, and allergy relief in the OTC space
• Rx offerings for cardiovascular, CNS, cancer, and diabetes—though that’s a smaller slice (26%)

Basically, it sells what most pharmacies can’t keep stocked during flu season—and what doctors prescribe all year round.

Financial Pulse Check

• Market Cap: ₹10,226 Cr
• Sales: ₹2,474 Cr
• OPM: 20.7%
• ROCE / ROE: 20.6% / 16.5% – efficient capital deployment
• Debt-to-equity: Just 0.09 – almost no leverage
• Cash in hand: ₹657 Cr – strong liquidity
• Stock P/E: 27.8 vs Industry PE of 33.8 – not cheap, but not overheated either

Why It Stands Out

In a market juggling Operation Sindoor shocks and Fed uncertainty, defensives like pharma tend to quietly outperform. Marksans has stable margins, global OTC exports, and a business that doesn’t care about rate hikes or oil prices.

The stock has corrected from its high of ₹359 and now trades around ₹226. With a strong balance sheet, near-zero debt, and a lean product model, this is one of those “no drama, just delivery” kinds of stories.

Bottom Line:
When markets go defensive, the money follows where risk is low and cash flow is steady. Marksans Pharma may not make the news—but it’s the kind of business that keeps your medicine cabinet (and maybe your portfolio) steady during geopolitical fevers.

What To Do Now: Your Action Plan

Operation Sindoor may have shaken the borders, but the market? Still holding its ground. Nifty is knocking on resistance, autos are in top gear, and defensives like pharma are quietly gathering momentum.

So, what’s the move?

• If you’re trading, keep an eye on 24,600. That’s your breakout level for Nifty. Until then, expect choppiness. Bank Nifty’s strength offers some hope, but PSU recovery is still questionable.
• If you’re investing, stories like Marksans Pharma show where quiet capital is going—cash-rich, low-debt businesses that aren’t headline chasers but grind out consistent growth.
• If you’re watching sectors, keep defence on your radar—Operation Sindoor could lead to more budget allocations, orders, and attention.

And if you want to track these setups without jumping across 5 apps…

Angel One makes it seamless with smart charts, live market scanners, and lightning-fast trades—all in one platform.
Stay ahead of the next move 👉 Check it out here

Related Articles

Tata Motors Demerger: What Is The Future of Tata Motors?